e-learning
resources
Munich 2006
Sunday 03.09.2006
Recent advances in asthma treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparative characteristics of inflammatory markers depending on treatment approaches in brittle asthma
L. M. Ogorodova, O. S. Kobyakova, A. E. Sazonov, T. S. Smetanenko (Tomsk, Russian Federation)
Source:
Annual Congress 2006 - Recent advances in asthma treatment
Session:
Recent advances in asthma treatment
Session type:
Poster Discussion
Number:
1801
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. M. Ogorodova, O. S. Kobyakova, A. E. Sazonov, T. S. Smetanenko (Tomsk, Russian Federation). Comparative characteristics of inflammatory markers depending on treatment approaches in brittle asthma. Eur Respir J 2006; 28: Suppl. 50, 1801
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Monitoring the inflammatory heterogeneity in asthma with multiple biomarkers for multidimensional endotyping
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017
Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 122s
Year: 2006
Overview and history of different ways of assessing and monitoring inflammatory airway diseases
Source: International Congress 2017 – PG6 Assessing and monitoring airway inflammation in asthma and chronic obstructive pulmonary disease
Year: 2017
Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
The peculiarities of the cascade of the bronchial asthma patients‘ cytokines depending on the stage of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 237s
Year: 2006
Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label
Source: Eur Respir J, 51 (1) 1701817; 10.1183/13993003.01817-2017
Year: 2018
Peculiarities of clinical-functional manifestations in severe bronchial asthma patients depending on the characteristics if local immunity
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Asthma phenotyping: Correlation between inflammatory phenotype, clinical parameters and associated comorbidities
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
Comparison of morphological and densitometric indicators of the inflammatory process activity for substantiation of the optimal terms of surgical treatment in patients with various forms of TB
Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes
Year: 2020
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Using characteristics of asthma phenotypes to determine exacerbation severity
Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Year: 2020
Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Application of biomarkers and patient characteristics to personalize asthma treatment for children
Source: International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma
Year: 2016
The cytokines profile peculiarities in patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 272s
Year: 2001
Clinical characteristics of severe asthma subphenotypes
Source: Annual Congress 2012 - Asthma: assessment and treatment
Year: 2012
Influence of different conditions on asthma severity
Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma
Year: 2007
Do allergic diseases and symptoms show the same pattern of genetic and environmental influences?
Source: Eur Respir J 2002; 20: Suppl. 38, 119s
Year: 2002
Linking phenotypes to personalised treatments in asthma and COPD
Source: Virtual Congress 2021 – Precision medicine in asthma and COPD
Year: 2021
The impact of different asthma phenotypes on the outcome
Source: Annual Congress 2012 - Asthma from childhood to adulthood: what factors predict the outcome?
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept